Form 4: Health Catalyst Executive Linda Llewelyn Sells Shares Under 10b5-1 Plan
SEC Form 4
Linda Llewelyn, Chief People Officer of Health Catalyst, Inc., sold 6,442 shares of common stock at a price of $7.8848 per share on December 16, 2024, under a pre-arranged trading plan.
Summary
- On December 16, 2024, Linda Llewelyn, the Chief People Officer of Health Catalyst, Inc. (HCAT), sold 6,442 shares of the company's common stock.
- The sale was executed at a price of $7.8848 per share.
- This transaction was conducted under a pre-arranged trading plan, specifically a written trading plan adopted on March 12, 2024, in accordance with Rule 10b5-1.
- Following the transaction, Llewelyn still beneficially owns 98,702 shares of Health Catalyst common stock.
Sentiment
Score: 5
Explanation: The document is a standard SEC Form 4 filing, indicating a routine stock sale by an executive under a pre-arranged trading plan. It doesn't inherently convey positive or negative sentiment.
Industry Context
Insider sales are a common occurrence, and the use of 10b5-1 plans allows insiders to sell shares without raising concerns about trading on material non-public information. The market typically views these sales in the context of the overall health and prospects of the company.
Key Dates
| Date | Description |
|---|---|
| March 12, 2024 | Date the Reporting Person adopted the written trading plan in accordance with Rule 10b5-1 |
| December 16, 2024 | Date of the stock sale transaction |
| December 18, 2024 | Date of signature on the Form 4 filing |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.